NO911852L - Fremgangsmaate for fremstilling av en ikke-racemisk form av furo (3,4-c) pyridin-derivater. - Google Patents

Fremgangsmaate for fremstilling av en ikke-racemisk form av furo (3,4-c) pyridin-derivater.

Info

Publication number
NO911852L
NO911852L NO91911852A NO911852A NO911852L NO 911852 L NO911852 L NO 911852L NO 91911852 A NO91911852 A NO 91911852A NO 911852 A NO911852 A NO 911852A NO 911852 L NO911852 L NO 911852L
Authority
NO
Norway
Prior art keywords
furo
preparing
procedure
pyridine derivatives
racemic form
Prior art date
Application number
NO91911852A
Other languages
English (en)
Other versions
NO180308B (no
NO911852D0 (no
NO180308C (no
Inventor
Charles R Eck
Paul C Ahrens
Rae Marie Saltzstein
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of NO911852D0 publication Critical patent/NO911852D0/no
Publication of NO911852L publication Critical patent/NO911852L/no
Publication of NO180308B publication Critical patent/NO180308B/no
Publication of NO180308C publication Critical patent/NO180308C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/06Peri-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/004Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO911852A 1990-05-14 1991-05-13 Fremgangsmåte for fremstilling av en tilnærmet ikke-racemisk form av furo (3,4-c) pyridin-derivater NO180308C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/523,238 US5130252A (en) 1990-05-14 1990-05-14 Resolution of furopyridine enantiomers and synthetic precursors thereof

Publications (4)

Publication Number Publication Date
NO911852D0 NO911852D0 (no) 1991-05-13
NO911852L true NO911852L (no) 1991-11-15
NO180308B NO180308B (no) 1996-12-16
NO180308C NO180308C (no) 1997-03-26

Family

ID=24084213

Family Applications (1)

Application Number Title Priority Date Filing Date
NO911852A NO180308C (no) 1990-05-14 1991-05-13 Fremgangsmåte for fremstilling av en tilnærmet ikke-racemisk form av furo (3,4-c) pyridin-derivater

Country Status (32)

Country Link
US (1) US5130252A (no)
JP (1) JPH05117277A (no)
KR (1) KR910020015A (no)
AR (1) AR247762A1 (no)
AT (1) AT400445B (no)
AU (1) AU642368B2 (no)
BE (1) BE1007016A3 (no)
CA (1) CA2042421C (no)
CH (1) CH682488A5 (no)
DE (1) DE4115681C2 (no)
DK (1) DK88991A (no)
DZ (1) DZ1499A1 (no)
ES (1) ES2033574B1 (no)
FI (1) FI97807C (no)
FR (1) FR2661919B1 (no)
GB (1) GB2244056B (no)
GR (1) GR1001593B (no)
HK (1) HK131993A (no)
IE (1) IE65891B1 (no)
IT (1) IT1248743B (no)
LU (1) LU87935A1 (no)
MA (1) MA22154A1 (no)
MY (1) MY107567A (no)
NL (1) NL194615C (no)
NO (1) NO180308C (no)
NZ (1) NZ238009A (no)
OA (1) OA09352A (no)
PT (1) PT97657B (no)
SE (1) SE510808C2 (no)
TN (1) TNSN91035A1 (no)
TW (1) TW226998B (no)
ZA (1) ZA913461B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0221494D0 (en) * 2002-09-16 2002-10-23 Generics Uk Ltd Novel processes for the preparation of 1.3-dihydro-6-methylfuro (3,4-c) pyndin derivatives
US20110251396A1 (en) * 2003-07-17 2011-10-13 Gilead Sciences, Inc. Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
US20060089374A1 (en) * 2003-07-17 2006-04-27 Glenn Cornett Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
US20050043391A1 (en) * 2003-07-17 2005-02-24 Fong Benson M. Combination therapies for treatment of hypertension and complications in patients with diabetes or metabolic syndrome
GB2423927A (en) * 2003-08-29 2006-09-13 Cotherix Inc Combination Of Cicletanine And An Oral Antidiabetic And/Or Blood Lipid-Lowering Agent For Treating Diabetes And Metabolic Syndrome
US20060154959A1 (en) * 2005-01-13 2006-07-13 Navitas Pharma Combination therapies of cicletanine and carvedilol
CA2593793A1 (en) * 2005-01-05 2006-07-13 Medicure International Inc. Compounds and methods for regulating triglyceride levels
US20070141174A1 (en) * 2005-01-13 2007-06-21 Navitas Pharma, Inc. Enantiomeric compositions of cicletanine, in combination with other agents, for the treatment of hypertension
US20080096915A1 (en) * 2005-01-13 2008-04-24 Greenberg Traurig LLP Compositions for the treatment of metabolic disorders
US20070105817A1 (en) * 2005-11-09 2007-05-10 Jim Page Use of cicletanine and other furopyridines for treatment of systolic-predominant hypertension, isolated systolic hypertension, elevated pulse pressure, and general hypertension
JP2010514841A (ja) * 2007-01-03 2010-05-06 グレン ブイ. コルネット, 肺疾患および心疾患の処置におけるシクレタニンおよびpkc阻害剤
EP2498605B1 (en) * 2009-10-29 2014-08-27 Merck Sharp & Dohme Corp. Diuretics

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN156817B (no) * 1981-02-10 1985-11-09 Scras
US4985365A (en) * 1981-11-28 1991-01-15 Sumitomo Chemical Company, Ltd. Process for producing optically active benzyl alcohol compound
EP0101076B1 (en) * 1982-08-13 1989-01-04 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Process for production of optically active oxazolidinone derivative
IN160104B (no) * 1983-04-05 1987-06-27 Scras
JPS59216590A (ja) * 1983-05-24 1984-12-06 Ube Ind Ltd 光学活性フエニルプロパルギルアルコ−ル誘導体の製法
GB8327817D0 (en) * 1983-10-18 1983-11-16 Scras 4-halo-furo-(3 4-c)-pyridine derivatives
GB8330517D0 (en) * 1983-11-16 1983-12-21 Scras 6-vinyl-furo-(3,4-c)pyridine derivatives
GB8330658D0 (en) * 1983-11-17 1983-12-29 Scras 7-carboxymethoxy-furo-(3,4-c)-pyridine derivatives
GB8402740D0 (en) * 1984-02-02 1984-03-07 Scras Furo-(3 4-c)-pyridine derivatives
JPS60224494A (ja) * 1984-04-24 1985-11-08 Nissan Chem Ind Ltd α−メチルベンジルアルコ−ル類の光学分割法
GB8414559D0 (en) * 1984-06-07 1984-07-11 Scras Pyridine derivatives
GB8427218D0 (en) * 1984-10-27 1984-12-05 Scras Pyridine derivatives
JPS61289899A (ja) * 1985-06-18 1986-12-19 Kanegafuchi Chem Ind Co Ltd 光学活性2−ハロ−1−フエニルエタノ−ルおよびそのエステルの製造法
US4916074A (en) * 1986-10-30 1990-04-10 Chisso Corporation Process for producing optically active compounds
JP2691986B2 (ja) * 1987-08-28 1997-12-17 チッソ株式会社 ピリジン骨格を有する光学活性化合物の製造法
DE3737335A1 (de) * 1987-11-04 1989-05-18 Basf Ag Verfahren zur herstellung eines biokatalysators und dessen verwendung zur razematspaltung
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
DE3990349T1 (de) * 1988-04-06 1990-04-26 Scras Stereospezifisches verfahren zur herstellung von enantiomeren von furo(3,4-c)pyridin, so erhaltene verbindungen und therapeutische zusammensetzungen auf basis dieser verbindungen
NL8801311A (nl) * 1988-05-20 1989-12-18 Stamicarbon Fenylglycidaatstereoisomeren, omzettingsprodukten daarvan met 2-nitrothiofenol en de bereiding van diltiazem.
GB8907480D0 (en) * 1989-04-03 1989-05-17 Scaras Societe De Conseils De Separation of insomers of furo(3,4-c)pyridine derivatives
GB8917168D0 (en) * 1989-07-27 1989-09-13 Scras Asymmetric synthesis of furo(3,4-c)pyridine derivatives

Also Published As

Publication number Publication date
NO180308B (no) 1996-12-16
FR2661919A1 (fr) 1991-11-15
TNSN91035A1 (fr) 1992-10-25
GR910100180A (en) 1992-07-30
US5130252A (en) 1992-07-14
IE911628A1 (en) 1991-11-20
GB2244056B (en) 1993-08-11
TW226998B (no) 1994-07-21
MY107567A (en) 1996-04-30
GB2244056A (en) 1991-11-20
ATA98291A (de) 1995-05-15
DZ1499A1 (fr) 2004-09-13
JPH05117277A (ja) 1993-05-14
ES2033574B1 (es) 1994-02-01
AU642368B2 (en) 1993-10-14
DE4115681A1 (de) 1991-11-21
IT1248743B (it) 1995-01-26
NL194615C (nl) 2002-09-03
DE4115681C2 (de) 2003-10-30
KR910020015A (ko) 1991-12-19
SE9101431D0 (sv) 1991-05-13
DK88991A (da) 1991-11-15
HK131993A (en) 1993-12-10
FI912315A (fi) 1991-11-15
OA09352A (fr) 1992-09-15
LU87935A1 (fr) 1992-03-03
ITMI911255A0 (it) 1991-05-08
FI912315A0 (fi) 1991-05-13
MA22154A1 (fr) 1991-12-31
IE65891B1 (en) 1995-11-29
NL9100749A (nl) 1991-12-02
ZA913461B (en) 1992-02-26
NL194615B (nl) 2002-05-01
CA2042421A1 (en) 1991-11-15
BE1007016A3 (fr) 1995-02-21
PT97657B (pt) 1998-09-30
AU7620091A (en) 1991-11-14
ITMI911255A1 (it) 1992-11-08
CH682488A5 (fr) 1993-09-30
GB9109810D0 (en) 1991-06-26
DK88991D0 (da) 1991-05-13
PT97657A (pt) 1992-02-28
FI97807B (fi) 1996-11-15
CA2042421C (en) 2000-08-22
SE510808C2 (sv) 1999-06-28
NZ238009A (en) 1992-11-25
NO911852D0 (no) 1991-05-13
AR247762A1 (es) 1995-03-31
AT400445B (de) 1995-12-27
SE9101431L (sv) 1991-11-15
NO180308C (no) 1997-03-26
GR1001593B (el) 1993-03-31
FR2661919B1 (fr) 1994-12-30
ES2033574A1 (es) 1993-03-16
FI97807C (fi) 1997-02-25

Similar Documents

Publication Publication Date Title
NO851921L (no) Fremgangsmaate for fremstilling av pyrido-imidazo-rifanycin-derivater.
NO872831L (no) FremgangsmŸte for fremstilling av nitrofuranderivater.
NO841322L (no) Fremgangsmaate for fremstilling av furo (3,4-c)-pyridin-derivater
NO851466L (no) Fremgangsmaate for fremstilling av 9a-aza-9a-homoery-tromycin-derivater.
NO913745D0 (no) Fremgangsmaate for fremstilling av 1,3-benzoksazinderivater
NO911852L (no) Fremgangsmaate for fremstilling av en ikke-racemisk form av furo (3,4-c) pyridin-derivater.
NO901070D0 (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
NO903780D0 (no) Fremgangsmaate til fremstilling av epipodofyllotoksinaltrosid-derivater.
NO901071L (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
NO904822D0 (no) Fremgangsmaate for fremstilling av pyridinderivater.
NO885435L (no) Fremgangsmaate for fremstilling av benzotiazepinderivater.
NO845038L (no) Fremgangsmaate for fremstilling av 4,5,6,7-tetrahydrotiazolo(5,4-c)pyridin-derivater
NO165107C (no) Fremgangsmaate for fremstilling av pyrido-imidazo-rifamycin-derivater.
NO841965L (no) Fremgangsmaate for fremstilling av 1,8-dihydroksy-10-acyl-9-antron-derivater
NO893713D0 (no) Fremgangsmaate for fremstilling av benzoksazolon-derivater.
NO892755L (no) Fremgangsmaate til fremstilling av 5,6,7,8-tetrahydro-4h-isoksazol(4,5-d)-azepin-3-olderivater.
NO880992D0 (no) Fremgangsmaate for fremstilling av pyridinderivater.
NO883398L (no) Fremgangsmaate for fremstilling av benzoksazin-derivater.
NO162071C (no) Fremgangsmaate for fremstilling av 6-(1-hydroksy-2-dimetylaminometyl-allyl)-furo-(3,4-c)-pyridin-derivater.
NO894707D0 (no) Fremgangsmaate for fremstilling av benzoxazinderivater.
NO167387C (no) Fremgangsmaate for fremstilling av 2-guanidinothiazolderivat.
NO903329L (no) Asymmetrisk syntese av furo(3,4-c) pyridin-derivater.
DK3289A (da) Fremgangsmaade til fremstilling af 5,8,13,14-tetrahydrobenz-(5,6)-isoindolo(2,1-b)-isoquinolin-8,13-dionderivater
SG125793G (en) Preparation of non-racemic furo (3,4-c) pyridine derivatives
ES537952A0 (es) Procedimiento de preparacion de un derivado de la pirano (3,2-g) quinoleina.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN NOVEMBER 2003